Whatever you do, don’t refer to LG’s incubator program LG Nova as a corporate venture capital (CVC) outfit.
LG Nova is the pointiest tip of the spear for LG, the company’s experimental playground to… [read more]
Month: January 2022
Following news that the FTC’s antitrust suit against Meta cleared a critical hurdle earlier this week, the agency is apparently also taking a sharp interest in the company’s VR business.
Bloomberg r… [read more]
Singapore-based industrial robotics firm Sesto this week announced a $5.7 million raise, featuring TRIVE, WTI GmbH and SEEDS Capital (Enterprise Singapores VC wing). The round follows a similarly siz… [read more]
To get a roundup of TechCrunchs biggest and most important stories delivered to your inbox every day at 3 p.m. PST, subscribe here.
Hello and welcome to Daily Crunch for January 14, 2022! I suppose … [read more]
Raising money is catastrophically challenging for female founders, and even harder for Black female founders.
Its a bold, even damning statement one I made in a recent discussion speculating whats t… [read more]
Join us on Science&Technology Nights with Prof. Okeanis Vaou on “Deep Brain Stimulation” The event is not intended to focus only on the topic, but participants can discuss and ask the Guest Speaker anything that would be of their interest, from scientific issues to career advices and beyond.
Βραδιές Επιστήμης & Τεχνολογίας have been designed for the sake of young Scientists of any background – everyone can participate, no matter if you are an Engineer, an IT or a Biologist, but also other Academics and Industry Experts are welcome to join. The discussion is open and participants may join us on stage to debate and ask their questions to the Guest Speaker(s). Working language: both Ελληνικά & English
Dr. Vaou completed her undergraduate and medical school training at the Semmelweis University of Medicine in Budapest, Hungary. She completed her neurological residency at New York Medical College and did a Fellowship in Movement Disorders and Sleep at Boston University Medical Center. Dr. Vaou is board-certified in Neurology and is fellowship trained in Movement Disorders and Sleep. She specializes in the management of Parkinson’s Disease and other movement disorders. Dr. Vaou follows patients who have undergone Deep Brain Stimulation. Dr. Vaou participates in clinical research evaluating novel pharmacological agents in Parkinson’s Disease.
Dr Aris Baras – Senior Vice President, Regeneron Pharmaceuticals, Inc. – on “The Power of Human Genetics: Rewriting the Rules in Drug Discovery and Development”
Prof. Emmanouil Dermitzakis – University of Geneva – on Principles of Biomedical Research & the promise of precision medicine
University of Cambridge Prof. Ludovic Vallier on “Stem Cell technologies to study the Liver in health & disease”
Professor Vassiliou Group from the University of Cambridge and PI at Wellcome – MRC Cambridge Stem Cell Institute seeks to understand the cell-autonomous and cell-non-autonomous processes involved in the transformation of normal to leukaemic haemopoietic stem cells and to identify genetic vulnerabilities of myeloid malignancies that can be exploited as targets of novel anti-leukaemic therapies. To achieve these aims the group uses three main approaches: Application of genetic screens to identify and investigate genetic vulnerabilities of acute myeloid leukaemia and related cancers in order to develop new therapeutic approaches Generation and study of bespoke mouse models of somatic mutation drivers of myeloid malignancies, in order to define their molecular, genomic and phenotypic effects on haemopoietic stem and progenitor cells Detection and tracking of the evolution of clonal haematopoiesis in healthy individuals, in order to understand the factors involved in leukaemic progression and develop new approaches for early detection.
